Brief: Xbiotech - Announced That Human Immune Donors Have Been Identified That Can Support Co's Development Of True Human Antibody Therapy For Covid-19
01/05/2020 22:58
May 1 (Reuters) - XBiotech Inc XBIT.O :
* XBIOTECH - ANNOUNCED THAT HUMAN IMMUNE DONORS HAVE BEEN
IDENTIFIED THAT CAN SUPPORT CO'S DEVELOPMENT OF TRUE HUMAN
ANTIBODY THERAPY FOR COVID-19
Source text for Eikon: ID:nGNE5MVhHB
Further company coverage: XBIT.O
((Briefs@thomsonreuters.com;))
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke